Effects of Supplement Containing Various Probiotics and Fermentation Products on Obesity
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to determine the effect of supplement combined various probiotics and fermentation products on body mass index, body fat mass, abdominal circumference, visceral fat mass, intestinal flora, and serum biochemical parameters in overweight subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Mar 2009
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 13, 2009
CompletedFirst Posted
Study publicly available on registry
April 14, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2009
CompletedOctober 29, 2009
October 1, 2009
April 13, 2009
October 28, 2009
Conditions
Outcome Measures
Primary Outcomes (1)
Body mass index
16 weeks
Secondary Outcomes (7)
Body fat mass
Week -4, Week 0, Week 4, Week 12
Abdominal circumference
Week -4, Week 0, Week 4, Week 12
Visceral fat area by CT scan
Week 0, Week 12
Intestinal flora
Week 0, Week 12
Serum lipid profile
Week -4, Week 0, Week 4, Week 12
- +2 more secondary outcomes
Study Arms (2)
1
EXPERIMENTAL2
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Healthy as based on medical history and physical examination
- BMI between 25 and 30 kg/m2
- Willing not to serve as blood donor during the study
- Informed consent signed
You may not qualify if:
- Food allergy
- Female subjects who are pregnant or nursing a child
- Participation in any clinical trial up to 90 days before Day 01 of this study
- Renal or hepatic dysfunction
- Heart disease
- Under medication
- Subjects who are taking functional food designed for weight loss or serum lipid reduction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hiroshima Universitylead
- Biostir, Inc.collaborator
- MIONA Co., Ltd.collaborator
Study Sites (1)
Hiroshima University
Hiroshima, Hiroshima, 734-8551, Japan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 13, 2009
First Posted
April 14, 2009
Study Start
March 1, 2009
Study Completion
September 1, 2009
Last Updated
October 29, 2009
Record last verified: 2009-10